Tag: adverse events (pharmacology)

Questions Remain as More ‘Twincretin’ Data in Diabetes Published

The streak of positive phase 3 trial results for the novel “twincretin” tirzepatide when treating patients with type 2 diabetes continued in a report in...

Drug or Exercise for Geriatric Depression? It Depends

Among older adults with mild-to-moderate depressive disorder diagnosed during a primary care visit, antidepressant medication or supervised group exercise sessions may decrease symptoms to a...

Most Patients Labeled Penicillin-Allergic Really Aren’t

Most people whose medical record says they are allergic to penicillin are not actually intolerant, an allergist said Thursday during the first day of sessions...

Safety Profile for Novel CGRP Beats Standard of Care

Atogepant, an oral, small-molecule, calcitonin gene–related peptide receptor antagonist that’s been in development as a preventive treatment for chronic migraine, has been found to have...

Don’t Stop Osteoporosis Meds for COVID-19 Vaccines, Say Experts

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. COVID-19 vaccines are safe and effective for patients taking osteoporosis medications,...

Expert Highlights Advances in DRESS

Mounting evidence suggests it’s a mistake to reject the diagnosis of drug reaction with eosinophilia and systemic symptoms, or DRESS, simply because the interval between...

SAMSON Pins Most Muscle Pain With Statins on the Nocebo Effect

A novel randomized trial taking on a vexing issue around one of the world’s most commonly prescribed medications has concluded that frequently intolerable statin side...

Prior Autoimmunity Does Not Predict Adverse Events

There is no evidence to support the idea that previous autoimmunity before or after alemtuzumab treatment predicts subsequent rare but serious and possibly life-threatening autoimmune...

New Guidance to Optimize Antipsychotic Treatment

A new consensus statement recommends monitoring antipsychotic blood levels, also known as therapeutic drug monitoring (TDM), to inform treatment decisions and optimize safety and efficacy....

Genetic Variant Might Contribute to Racial Disparity in COVID-19 Cardiac Mortality

NEW YORK (Reuters Health) — A genetic variant that increases the risk of drug-induced long QT syndrome (LQTS) and sudden cardiac death (SCD) could contribute to...

Hydroxychloroquine-related QTc-Interval Prolongations Mount

The potential for serious arrhythmias from hydroxychloroquine treatment of COVID-19 patients received further documentation from a pair of studies released on May 1, casting further doubt...